These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9582530

  • 1. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.
    Heine B, Hummel M, Müller M, Heicappell R, Miller K, Stein H.
    J Pathol; 1998 Jan; 184(1):71-6. PubMed ID: 9582530
    [Abstract] [Full Text] [Related]

  • 2. [Telomerase activity as marker of superficial tumor of the bladder].
    Arias Fúnez F, Fernández Fernández E, Escudero Barrilero A, Moyano Jato A, Caso Peláez E.
    Arch Esp Urol; 2000 Apr; 53(3):231-6. PubMed ID: 10851728
    [Abstract] [Full Text] [Related]

  • 3. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.
    Gelmini S, Crisci A, Salvadori B, Pazzagli M, Selli C, Orlando C.
    Clin Cancer Res; 2000 Jul; 6(7):2771-6. PubMed ID: 10914723
    [Abstract] [Full Text] [Related]

  • 4. Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer.
    Dettlaff-Pokora A, Matuszewski M, Schlichtholz B.
    Cancer Lett; 2005 May 10; 222(1):83-8. PubMed ID: 15837544
    [Abstract] [Full Text] [Related]

  • 5. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
    Bian W, Xu Z.
    Int J Urol; 2007 Feb 10; 14(2):108-11. PubMed ID: 17302565
    [Abstract] [Full Text] [Related]

  • 6. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
    Lee DH, Yang SC, Hong SJ, Chung BH, Kim IY.
    Clin Cancer Res; 1998 Mar 10; 4(3):535-8. PubMed ID: 9533519
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G, Han W, Zhang ZF, Cordon-Cardo C, Saigo P, Fair WR, Herr H, Kim N, Moore MA.
    Clin Cancer Res; 1997 Sep 10; 3(9):1593-8. PubMed ID: 9815848
    [Abstract] [Full Text] [Related]

  • 8. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M, Omran Z, Nosseir M, Lotfy A, Swellam T.
    APMIS; 2009 Jan 10; 117(1):45-52. PubMed ID: 19161536
    [Abstract] [Full Text] [Related]

  • 9. Urine telomerase activity for the detection of bladder cancer in females.
    Bravaccini S, Sanchini MA, Granato AM, Gunelli R, Nanni O, Amadori D, Calistri D, Silvestrini R.
    J Urol; 2007 Jul 10; 178(1):57-61. PubMed ID: 17574060
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.
    Siracusano S, Niccolini B, Knez R, Tiberio A, Benedetti E, Bonin S, Ciciliato S, Pappagallo GL, Belgrano E, Stanta G.
    Eur Urol; 2005 Mar 10; 47(3):327-33. PubMed ID: 15716196
    [Abstract] [Full Text] [Related]

  • 12. Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise.
    Cassel A, Rahat MA, Lahat N, Lindenfeld N, Mecz Y, Stein A.
    J Urol; 2001 Sep 10; 166(3):841-4. PubMed ID: 11490230
    [Abstract] [Full Text] [Related]

  • 13. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer.
    Eissa S, Swellam M, Ali-Labib R, Mansour A, El-Malt O, Tash FM.
    J Urol; 2007 Sep 10; 178(3 Pt 1):1068-72. PubMed ID: 17644139
    [Abstract] [Full Text] [Related]

  • 14. Comparison of screening methods in the detection of bladder cancer.
    Ramakumar S, Bhuiyan J, Besse JA, Roberts SG, Wollan PC, Blute ML, O'Kane DJ.
    J Urol; 1999 Feb 10; 161(2):388-94. PubMed ID: 9915409
    [Abstract] [Full Text] [Related]

  • 15. [Telomerase activity: a molecular marker for early diagnosis of bladder tumor].
    Calistri D, Sanchini A, Amadori D, Silvestrini R.
    Recenti Prog Med; 2007 Feb 10; 98(2):74-8. PubMed ID: 17439065
    [Abstract] [Full Text] [Related]

  • 16. Telomerase activity in patients with transitional cell carcinoma: a preliminary study.
    Rahat MA, Lahat N, Gazawi H, Resnick MB, Sova Y, Ben-Ari G, Cohen M, Stein A.
    Cancer; 1999 Feb 15; 85(4):919-24. PubMed ID: 10091771
    [Abstract] [Full Text] [Related]

  • 17. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L, Bialkowska-Hobrzanska H, Bukala B, Nott L, Razvi H.
    Can J Urol; 2004 Dec 15; 11(6):2438-44. PubMed ID: 15636669
    [Abstract] [Full Text] [Related]

  • 18. Telomerase and other novel approaches to bladder cancer detection.
    Bennett A.
    Clin Lab Sci; 2008 Dec 15; 21(3):185-90; quiz 191-2, following 192. PubMed ID: 18678141
    [Abstract] [Full Text] [Related]

  • 19. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.
    Ito H, Kyo S, Kanaya T, Takakura M, Koshida K, Namiki M, Inoue M.
    Clin Cancer Res; 1998 Nov 15; 4(11):2807-10. PubMed ID: 9829746
    [Abstract] [Full Text] [Related]

  • 20. Telomerase activity is correlated with lower grade and lower stage bladder carcinomas.
    Okumura A, Mizuno I, Nagakawa O, Fuse H.
    Int J Urol; 2004 Dec 15; 11(12):1082-6. PubMed ID: 15663679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.